Policy

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

A new study has has revealed the variation in the number of people being diagnosed with liver cancer across the UK.

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.

The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.

Cancer Research UK today published its gender pay gap report in response to the UK’s government’s requirement.

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.